Business · 30/03/1995Updated: 10/18/2026 · 1 min read
FDA Withdraws Regulation for Bleomycin Sulfate Antibiotic Drug
Summary
The US Food and Drug Administration (FDA) is withdrawing a regulation that set standards for nonsterile bleomycin sulfate bulk drug substance, allowing for public comment before proposing new standards in a future Federal Register issue.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →